Back to Brazil Overview
Exigência & Inspection Defense
ANVISA Queries, Technical Requirements & Inspection Response
ANVISA questions should be answered by addressing the regulatory concern behind the request, not by simply adding documents. A technically complete but poorly structured response can create additional review cycles if it does not explain why the evidence resolves the specific issue raised.
When This Support Is Needed
An official ANVISA exigência or technical deficiency letter has been received
A Class III or IV registration dossier has been questioned during pre-market technical review
BGMP / CBPF on-site inspection non-conformances require root-cause analysis and formal CAPA response
ANVISA requests clarification on testing, labeling, classification, clinical data, or manufacturing controls
What We Challenge Before Submission
Does the response answer the actual regulatory question directly and defensibly?
Is every technical statement supported by underlying objective study data?
Do revised documents remain strictly consistent with the remainder of the technical dossier?
Is new laboratory testing genuinely required or can existing evidence be scientifically justified?
Does the corrective action address systemic quality root causes rather than only the single observed finding?
Our Response Support Methodology
Question-by-question regulatory and technical assessment of ANVISA's query
Root-cause analysis of the underlying regulatory concern
Evidence-gap determination and scientific justification strategy
Cross-functional response planning across R&D, clinical, quality, and regulatory teams
Dossier section revision and document harmonization
Supplementary test-report and study protocol review
Portuguese labeling, package artwork, and IFU correction strategy
Risk-management file and clinical/performance evidence cross-referencing
CAPA response package support for BGMP inspection observations
Final response package quality check and electronic submission via Solicita
Senior Regulatory Methodology:
We first determine why ANVISA is asking the question. Is the issue missing evidence, inconsistent documentation, insufficient testing, weak classification rationale, certificate-scope mismatch, or an actual product/compliance gap? The response strategy is then built around closing that specific concern.
Resolve ANVISA Exigências with Expert Regulatory Justification
Our team deconstructs technical queries, prepares evidence-based response packages, and secures timely approvals.